Essais cliniques en cancérologie à Lausanne
77 essais ouverts avec au moins un centre à Lausanne, d'après ClinicalTrials.gov, mis à jour le 28 octobre 2026.
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.
Essais ouverts
- Observational Study Protocol: LIVER-R
NCT06252753Recrutement en cours
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Recrutement en coursPhase 3
- A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
NCT05916313Recrutement en coursPhase 1
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
NCT07574047Recrutement en coursPhase 2
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
NCT03970447Recrutement en coursPhase 2 · Phase 3
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
NCT06561386Recrutement en coursPhase 3
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
NCT07361510Recrutement en coursPhase 3
- The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT05890677Recrutement en cours
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
NCT06843447Recrutement en coursPhase 1 · Phase 2
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
NCT07099898Recrutement en coursPhase 3
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674Recrutement en coursPhase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Recrutement en coursPhase 3
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
NCT06712316Recrutement en coursPhase 2 · Phase 3
- Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779Recrutement en coursPhase 3
- Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
NCT05948943Recrutement en coursPhase 2 · Phase 3
- Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980Recrutement en coursPhase 2
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849Recrutement en coursPhase 3
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073Recrutement en coursPhase 3
- A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
NCT07793942Pas encore en recrutementPhase 2
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581Recrutement en coursPhase 3
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693Recrutement en coursPhase 3
- Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
NCT07600749Recrutement en coursPhase 1
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
NCT05902169Recrutement en coursPhase 3
- FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Recrutement en coursPhase 2 · Phase 3
- A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
NCT06392386Recrutement en coursPhase 2 · Phase 3
- A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277Recrutement en coursPhase 3
- Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT05727904Recrutement en coursPhase 3
- A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171Recrutement en coursPhase 2
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT07365241Recrutement en coursPhase 3
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Recrutement en coursPhase 3
- A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07023627Recrutement en coursPhase 2
- Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors
NCT07368153Recrutement en coursPhase 2
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT04221542Recrutement en coursPhase 1
- DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Recrutement en cours
- A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868Recrutement en coursPhase 2 · Phase 3
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Recrutement en coursPhase 1
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
NCT05836324Recrutement en coursPhase 1
- Efficacy and Safety of the CG-100 Intraluminal Bypass Device
NCT04184973Recrutement en cours
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Recrutement en coursPhase 1
- Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
NCT07140900Recrutement en coursPhase 1
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Recrutement en coursPhase 2
- Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
NCT03180918Recrutement en cours
- A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588Recrutement en coursPhase 3
- NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
NCT06889766Recrutement en coursPhase 1
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
NCT06284317Recrutement en coursPhase 3
- Personalized Rehabilitation With Organ-Preserving Robotic RESA in Head and Neck Cancer
NCT07546045Recrutement en cours
- Early Pulmonary Dysfunction in Childhood Cancer Patients
NCT05427136Recrutement en cours
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494Recrutement en coursPhase 3
- [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
NCT06794372Recrutement en coursPhase 2
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05580562Recrutement en coursPhase 3
- First in Human Study of T3P-Y058-739 (T3P)
NCT05120596Recrutement en coursPhase 1 · Phase 2
- Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes
NCT07518485Pas encore en recrutementPhase 2
- Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study
NCT07479407Pas encore en recrutement
- Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
NCT07263438Recrutement en coursPhase 2
- Surgery for Recurrent Glioblastoma
NCT02394626Recrutement en coursPhase 2
- NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
NCT06452394Recrutement en coursPhase 2
- Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
NCT06835049Recrutement en coursPhase 2
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
NCT05259605Recrutement en cours
- PTX3-targeted Antifungal Prophylaxis
NCT03828773Recrutement en cours
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
NCT05726786Recrutement en coursPhase 3
- European Myeloma Network (EMN) Sample Project
NCT06237803Recrutement en cours
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978Recrutement en coursPhase 3
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980Recrutement en cours
- Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
NCT06776172Recrutement en cours
- The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Recrutement en cours
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276Recrutement en coursPhase 3
- 68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma
NCT06911021Pas encore en recrutement
- Improving Hepatocellular Carcinoma Screening
NCT05828446Recrutement en cours
- Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
NCT06482489Recrutement en cours
- Swiss Severe Asthma Register
NCT03984253Recrutement en cours
- EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
NCT05688241Pas encore en recrutementPhase 1 · Phase 2
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Recrutement en cours
- Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
NCT06100718Recrutement en cours
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907Recrutement en coursPhase 1 · Phase 2
- Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
NCT01601171Recrutement en cours
- Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
NCT04045691Recrutement en cours
- Optimization of the Targeted Anticancer Therapies
NCT04484064Recrutement en cours